Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells

Schizophrenia is a complex psychiatric disorder that exhibits an interconnection between the immune system and the brain. Experimental and clinical studies have suggested the presence of neuroinflammation in schizophrenia. In the present study, the effect of antipsychotic drugs, including clozapine,...

Full description

Bibliographic Details
Main Authors: Vijayasree V. Giridharan, Giselli Scaini, Gabriela D. Colpo, Tejaswini Doifode, Omar F. Pinjari, Antônio L. Teixeira, Fabricia Petronilho, Danielle Macêdo, João Quevedo, Tatiana Barichello
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/3/577
id doaj-cc15d74bef944025b2b4db7c4cdc28f5
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Vijayasree V. Giridharan
Giselli Scaini
Gabriela D. Colpo
Tejaswini Doifode
Omar F. Pinjari
Antônio L. Teixeira
Fabricia Petronilho
Danielle Macêdo
João Quevedo
Tatiana Barichello
spellingShingle Vijayasree V. Giridharan
Giselli Scaini
Gabriela D. Colpo
Tejaswini Doifode
Omar F. Pinjari
Antônio L. Teixeira
Fabricia Petronilho
Danielle Macêdo
João Quevedo
Tatiana Barichello
Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells
Cells
microglia
poly (i:c)
inflammation
nlrp3
cytokines
schizophrenia
author_facet Vijayasree V. Giridharan
Giselli Scaini
Gabriela D. Colpo
Tejaswini Doifode
Omar F. Pinjari
Antônio L. Teixeira
Fabricia Petronilho
Danielle Macêdo
João Quevedo
Tatiana Barichello
author_sort Vijayasree V. Giridharan
title Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells
title_short Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells
title_full Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells
title_fullStr Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells
title_full_unstemmed Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells
title_sort clozapine prevents poly (i:c) induced inflammation by modulating nlrp3 pathway in microglial cells
publisher MDPI AG
series Cells
issn 2073-4409
publishDate 2020-02-01
description Schizophrenia is a complex psychiatric disorder that exhibits an interconnection between the immune system and the brain. Experimental and clinical studies have suggested the presence of neuroinflammation in schizophrenia. In the present study, the effect of antipsychotic drugs, including clozapine, risperidone, and haloperidol (10, 20 and 20 μM, respectively), on the production of IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-17, IL-18, INF-γ, and TNF-α was investigated in the unstimulated and polyriboinosinic-polyribocytidilic acid [poly (I:C)]-stimulated primary microglial cell cultures. In the unstimulated cultures, clozapine, risperidone, and haloperidol did not influence the cytokine levels. Nevertheless, in cell cultures under strong inflammatory activation by poly (I:C), clozapine reduced the levels of IL-1α, IL-1β, IL-2, and IL-17. Risperidone and haloperidol both reduced the levels of IL-1α, IL-1β, IL-2, and IL-17, and increased the levels of IL-6, IL-10, INF-γ, and TNF-α. Based on the results that were obtained with the antipsychotic drugs and observing that clozapine presented with a more significant anti-inflammatory effect, clozapine was selected for the subsequent experiments. We compared the profile of cytokine suppression obtained with the use of NLRP3 inflammasome inhibitor, CRID3 to that obtained with clozapine, to test our hypothesis that clozapine inhibits the NLRP3 inflammasome. Clozapine and CRID3 both reduced the IL-1α, IL-1β, IL-2, and IL-17 levels. Clozapine reduced the level of poly (I:C)-activated NLRP3 expression by 57%, which was higher than the reduction thay was seen with CRID3 treatment (45%). These results suggest that clozapine might exhibit anti-inflammatory effects by inhibiting NLRP3 inflammasome and this activity is not typical with the use of other antipsychotic drugs under the conditions of strong microglial activation.
topic microglia
poly (i:c)
inflammation
nlrp3
cytokines
schizophrenia
url https://www.mdpi.com/2073-4409/9/3/577
work_keys_str_mv AT vijayasreevgiridharan clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells
AT giselliscaini clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells
AT gabrieladcolpo clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells
AT tejaswinidoifode clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells
AT omarfpinjari clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells
AT antoniolteixeira clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells
AT fabriciapetronilho clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells
AT daniellemacedo clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells
AT joaoquevedo clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells
AT tatianabarichello clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells
_version_ 1725322323205029888
spelling doaj-cc15d74bef944025b2b4db7c4cdc28f52020-11-25T00:31:47ZengMDPI AGCells2073-44092020-02-019357710.3390/cells9030577cells9030577Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial CellsVijayasree V. Giridharan0Giselli Scaini1Gabriela D. Colpo2Tejaswini Doifode3Omar F. Pinjari4Antônio L. Teixeira5Fabricia Petronilho6Danielle Macêdo7João Quevedo8Tatiana Barichello9Translational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USALaboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Health Sciences Unit, University of South Santa Catarina, Tubarão, 88700-000 Santa Catarina, BrazilNeuropsychopharmacology Laboratory, Drug Research, and Development Center, Faculty of Medicine, Universidade Federal do Ceará, 60020-181 Fortaleza CE, Brazil; National Institute for Translational Medicine (INCT-TM, CNPq), 14000-000 Ribeirão Preto, SP, BrazilTranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USASchizophrenia is a complex psychiatric disorder that exhibits an interconnection between the immune system and the brain. Experimental and clinical studies have suggested the presence of neuroinflammation in schizophrenia. In the present study, the effect of antipsychotic drugs, including clozapine, risperidone, and haloperidol (10, 20 and 20 μM, respectively), on the production of IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-17, IL-18, INF-γ, and TNF-α was investigated in the unstimulated and polyriboinosinic-polyribocytidilic acid [poly (I:C)]-stimulated primary microglial cell cultures. In the unstimulated cultures, clozapine, risperidone, and haloperidol did not influence the cytokine levels. Nevertheless, in cell cultures under strong inflammatory activation by poly (I:C), clozapine reduced the levels of IL-1α, IL-1β, IL-2, and IL-17. Risperidone and haloperidol both reduced the levels of IL-1α, IL-1β, IL-2, and IL-17, and increased the levels of IL-6, IL-10, INF-γ, and TNF-α. Based on the results that were obtained with the antipsychotic drugs and observing that clozapine presented with a more significant anti-inflammatory effect, clozapine was selected for the subsequent experiments. We compared the profile of cytokine suppression obtained with the use of NLRP3 inflammasome inhibitor, CRID3 to that obtained with clozapine, to test our hypothesis that clozapine inhibits the NLRP3 inflammasome. Clozapine and CRID3 both reduced the IL-1α, IL-1β, IL-2, and IL-17 levels. Clozapine reduced the level of poly (I:C)-activated NLRP3 expression by 57%, which was higher than the reduction thay was seen with CRID3 treatment (45%). These results suggest that clozapine might exhibit anti-inflammatory effects by inhibiting NLRP3 inflammasome and this activity is not typical with the use of other antipsychotic drugs under the conditions of strong microglial activation.https://www.mdpi.com/2073-4409/9/3/577microgliapoly (i:c)inflammationnlrp3cytokinesschizophrenia